Evidence map›Paper›PMID 28702030›Full record

ArticleFrontiers in immunology2017

Enrichment of HLA Types and Single-Nucleotide Polymorphism Associated With Non-progression in a Strictly Defined Cohort of HIV-1 Controllers.

Samantha J Westrop, Alexander T H Cocker, Adriano Boasso, Ann K Sullivan, Mark R Nelson, Nesrina Imami

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Samantha J WestropCentre for Immunology and Vaccinology, Imperial College London, London, United Kingdom.
Alexander T H CockerCentre for Immunology and Vaccinology, Imperial College London, London, United Kingdom.
Adriano BoassoCentre for Immunology and Vaccinology, Imperial College London, London, United Kingdom.
Ann K SullivanDepartment of HIV/GU Medicine, Chelsea and Westminster Hospital, London, United Kingdom.
Mark R NelsonDepartment of HIV/GU Medicine, Chelsea and Westminster Hospital, London, United Kingdom.
Nesrina ImamiCentre for Immunology and Vaccinology, Imperial College London, London, United Kingdom.
Imperial College London · GBChelsea and Westminster Hospital · GB

Funding

Medical Research Council G0501957
6 · The paper itself

Abstract

HIV-1 controllers (HIC) are extremely rare patients with the ability to control viral replication, maintain unchanging CD4 T-cell count, and evade disease progression for extensive periods of time, in the absence of antiretroviral therapy. In order to establish the representation of key genetic correlates of atypical disease progression within a cohort of HIV-1

Indexed as

disease progressionelite controllersHIV-1HLA antigenssingle-nucleotide polymorphism

Identifiers

PMID28702030
PMCPMC5484768
OpenAlexW2698273306

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.